The release of GLP-1 from gut L cells is inhibited by low extracellular pH.
Where this comes from
- Record sourced from PubMed, PMID 39238194.
- Also identified by DOI 10.1002/oby.24125 and PMC identifier 11492159.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
The intestinal luminal pH profile varies from stomach to rectum and becomes disrupted in diseases. However, little is known about the pH dependence of incretin hormone secretion, with most in vitro studies having failed to consider this modulatory factor or having used nonphysiological buffer systems. Here, we report the extracellular pH (pHe) dependence of glucagon-like peptide-1 (GLP-1) exocytosis from L cells. The pHe dependence of GLP-1 release from GLUTag cells and murine ex vivo primary gut cultures was detected by ELISA. GLP-1 release was measured over a range of pHe under a physiological (CO<sub>2</sub>/HCO<sub>3</sub> <sup>-</sup>) buffering regime and in its absence (HEPES buffer). The relationship between intracellular pH (pHi) and pHe was mapped given that at least some component of pH sensitivity is likely to be intracellular. GLP-1 secretion from L cells was pHe-dependent and stimulated under alkaline conditions. In the absence of glucose or extracellular calcium, secretion remained at a pHe-insensitive baseline. pHi followed changes in pHe, but the relationship was offset to more alkaline levels in the absence of CO<sub>2</sub>/HCO<sub>3</sub> <sup>-</sup> buffer and became shallower if [Cl<sup>-</sup>] changes that normally accompany [HCO<sub>3</sub> <sup>-</sup>] changes were compensated iso-osmotically with gluconate. GLP-1 secretion is sensitive to pHe and the buffer present. Exploiting this mechanism therapeutically may benefit patients with obesity.
Medical subject headings
- Glucagon-Like Peptide 1
- Exocytosis